Subsequent Events	3 Months Ended
Oct. 31, 2017
Subsequent Events [Abstract]
Subsequent Events	Note 9 - Subsequent Events: The Company has evaluated subsequent events occurring after the balance sheet date through the date the unaudited condensed interim consolidated financial statements were issued and identified the following for disclosure: On November 27, 2017, Generex Biotechnology Corporation filed a Certificate of Amendment to its Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 2,450,000 shares to 750,000,000 shares. Since October 31, 2017, the former majority shareholder of HDS has made further advances and/or loans to HDS totaling $36,757 as of the date of this filing. On December 8, 2017, Core Tech Solutions, Inc. notified the Company that they are terminating the letter of intent contemplating the Company’s acquisition of a controlling interest of the outstanding capital stock of Core Tech Solutions, Inc.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration